Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
83dJcpUjTMTTL7ck